Pacific Biosciences of California, Inc. Third Quarter 2017 Financial Results Call

Share This.....Share on LinkedInTweet about this on TwitterShare on FacebookShare on Google+Email this to someone

MENLO PARK, Calif., Oct. 20, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its Third Quarter 2017 Financial Results on Thursday, November 2, 2017, at 4:30pm Eastern Time.
The call will be webcast and may be accessed at Pacific Biosciences’ website at:  http://investor.pacificbiosciences.com/.Date:  November 2, 2017Time:  4:30pm ETListen via Internet:  http://investor.pacificbiosciences.com/Toll-free:  888.366.7247International:  707.287.9330Audience Passcode: 3297738Replay:  http://investor.pacificbiosciences.comAbout Pacific BiosciencesPacific Biosciences of California, Inc. (NASDAQ:PACB) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) technology, Pacific Biosciences’ products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences’ technology provides high accuracy, ultra-long reads, uniform coverage, and is the only DNA sequencing technology that provides the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com.Pacific Biosciences
Trevin Rard
650.521.8450
ir@pacificbiosciences.com